Literature DB >> 1736291

Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant.

J E Coe1, K G Ishak, J M Ward, M J Ross.   

Abstract

Zeranol (alpha-zearalanol) is a beta-resorcylic acid lactone (RAL) that has estrogen activity. It is synthesized by molds and is difficult to avoid in human food products. We tested the ability of this mycoestrogen to damage the liver of the Armenian hamster, a rodent that is especially sensitive to hepatotoxic effects of exogenous estrogens. Zeranol induced acute hepatotoxicity and, subsequently, hepatic carcinogenesis; both effects were blocked by tamoxifen, suggesting estrogen receptor mediation. Because zeranol is acting alone as a primary initiator of hepatic neoplasms, this model provides an unusual opportunity to study the pathogenesis of estrogen-initiated tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736291      PMCID: PMC48390          DOI: 10.1073/pnas.89.3.1085

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis.

Authors:  J D Yager; Y E Shi
Journal:  Prev Med       Date:  1991-01       Impact factor: 4.018

2.  Clinicopathological characteristics of hepatocellular carcinoma bearing Mallory bodies: an autopsy study.

Authors:  M Hoso; Y Nakanuma
Journal:  Liver       Date:  1990-10

Review 3.  Hepatocarcinogenesis: a dynamic cellular perspective.

Authors:  E Farber; D S Sarma
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

Review 4.  Risk assessment of the mycotoxin zearalenone.

Authors:  T Kuiper-Goodman; P M Scott; H Watanabe
Journal:  Regul Toxicol Pharmacol       Date:  1987-09       Impact factor: 3.271

Review 5.  Trichothecenes, zearalenone, and other carcinogenic metabolites of Fusarium and related microfungi.

Authors:  R Schoental
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

6.  Oral contraceptives and hepatocellular carcinoma.

Authors:  J Neuberger; D Forman; R Doll; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

7.  Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation.

Authors:  K G Nelson; T Takahashi; N L Bossert; D K Walmer; J A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 8.  Zeranol--a 'nature-identical' oestrogen?

Authors:  D G Lindsay
Journal:  Food Chem Toxicol       Date:  1985-08       Impact factor: 6.023

Review 9.  The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.

Authors:  I B Weinstein
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

Review 10.  Mitogenic regulation of normal and malignant breast epithelium.

Authors:  M E Lippman; R B Dickson
Journal:  Yale J Biol Med       Date:  1989 Sep-Oct
View more
  6 in total

1.  Role of zearalenone lactonase in protection of Gliocladium roseum from fungitoxic effects of the mycotoxin zearalenone.

Authors:  Jan Utermark; Petr Karlovsky
Journal:  Appl Environ Microbiol       Date:  2006-11-17       Impact factor: 4.792

2.  Zeranol may increase the risk of leptin-induced neoplasia in human breast.

Authors:  Pingping Xu; Weiping Ye; Saiyi Zhong; Robert Jen; Hong Li; Eric Feng; Shu-Hong Lin; Jie-Yu Liu; Young C Lin
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

3.  Hormone Use in Food Animal Production: Assessing Potential Dietary Exposures and Breast Cancer Risk.

Authors:  Keeve E Nachman; Tyler J S Smith
Journal:  Curr Environ Health Rep       Date:  2015-03

4.  Zeranol down-regulates p53 expression in primary cultured human breast cancer epithelial cells through epigenetic modification.

Authors:  Weiping Ye; Pingping Xu; Robert Jen; Eric Feng; Saiyi Zhong; Hong Li; Shu-Hong Lin; Jie-Yu Liu; Young C Lin
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

5.  Synergistic estrogenic effects of Fusarium and Alternaria mycotoxins in vitro.

Authors:  Katharina Vejdovszky; Kathrin Hahn; Dominik Braun; Benedikt Warth; Doris Marko
Journal:  Arch Toxicol       Date:  2016-07-11       Impact factor: 5.153

6.  A sensitive zonagenetic assay for rapid in vitro assessment of estrogenic potency of xenobiotics and mycotoxins.

Authors:  T Celius; T B Haugen; T Grotmol; B T Walther
Journal:  Environ Health Perspect       Date:  1999-01       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.